Iovance Biotherapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $3.41 billion, with shareholders equity totaling $812.66 million.
The company employs approximately 241 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Iovance Biotherapeutics Inc. reported $378.98 million in revenue, generating net income of $-220.54 million.
Key financial metrics include a P/E ratio of -15.46, a price-to-book (P/B) ratio of 4.20, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker IOVA.